The ML4 Foundation Board of Directors is pleased to report continued funding to:
- Dr. Yulia Grishchuk (Massachusetts General Hospital) for her proposal, Targeting Neuroinflammation to Treat Mucolipidosis Type IV
- Dr. Tony Futerman (Weizmann Institute) for his proposal, Gene Array Analysis and Gene Expression in MLIV
- Dr. Diego Medina (TIGEM) for his proposal, High content imaging approaches to investigate TRPML1 modulation and identify compounds inducing clearance in Mucolipidosis type IV.
See more about our funded research at Funded Research.
